Michael Roemer

This inventor holds 19 USPTO granted patents and 38 published patent applications, primarily in Cancer Immunotherapy. Top assignee: Immatics Biotechnologies Gmbh. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Roemer. Retrieved from https://idiyas.com/inventor/michael-roemer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 38)

% Patents Active = 100.0

Average Co-Inventor Count = 8.5

ph-index = 2

Forward Citations = 6(Granted Patents)

Company Filing History:

19 out of 728

Immatics Biotechnologies Gmbh

patents

Years Active: 2022-2025

Loading Chart...

Areas of Expertise:

HLA Peptides

B*07 Restricted Peptides

B*08 Restricted Peptides

Immunotherapy

Cancer Treatment

Peptide Combination

Amidated Peptides

Deamidated Peptides

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12318407 - Peptides displayed by HLA for use in immunotherapy against different types of cancers (2025-06-03),

2. 12290530 - Peptides displayed by HLA for use in immunotherapy against different types of cancers (2025-05-06),

3. 12285443 - Peptides displayed by HLA for use immunotherapy against different types of cancers (2025-04-29),

4. 12274716 - Peptides displayed by HLA for use immunotherapy against different types of cancers (2025-04-14),

5. 12257269 - Peptides displayed by HLA for use in immunotherapy against different types of cancers (2025-03-25),

6. 12246039 - Peptides displayed by HLA for use in immunotherapy against different types of cancers (2025-03-11),

7. 12227556 - Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods (2025-02-18),

8. 12202878 - Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods (2025-01-21),

9. 12195516 - Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods (2025-01-14),

10. 12084486 - Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods (2024-09-10),

11. 11957716 - Peptides displayed by HLA for use in immunotherapy against different types of cancers (2024-04-16),

12. 11952409 - Amidated peptides and their deamidated counterparts displayed by non-HLA-A*02 for use in immunotherapy against different types of cancers preliminary class (2024-04-09),

13. 11891427 - Amidated peptides and their deamidated counterparts displayed by non-HLA-a*02 for use in immunotherapy against different types of cancers (2024-02-06),

14. 11779605 - Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methods (2023-10-10),

15. 11732021 - Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods (2023-08-22),

Title: The Innovative Journey of Michael Roemer

Introduction:

Michael Roemer is a distinguished inventor based in Tuebingen, Germany. With a passion for creating groundbreaking solutions, Roemer has made significant contributions to the field of technology through his inventive spirit and dedication to innovation.

Latest Patents:

Roemer's latest patents focus on advancements in renewable energy technologies, particularly in the development of solar power systems that are more efficient and cost-effective. His innovative approach to harnessing solar energy has garnered attention for its potential to revolutionize the renewable energy industry.

Career Highlights:

Throughout his career, Roemer has been at the forefront of technological innovation, holding key roles in leading research institutions and technology companies. His expertise in engineering and renewable energy has led to the successful development of cutting-edge solutions that address pressing global challenges.

Collaborations:

Roemer has collaborated with top researchers, engineers, and industry experts to bring his inventions to life. His collaborative efforts have resulted in the creation of patented technologies that have the potential to shape the future of sustainable energy production and consumption.

Conclusion:

In conclusion, Michael Roemer's innovative spirit and dedication to technological advancement have established him as a prominent figure in the field of renewable energy. His contributions to the development of solar power systems underscore his commitment to creating a more sustainable future for generations to come.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

38 patents pending: